1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Scope of Study 19
3.2 Research Objective 19
3.3 List of Assumptions 19
3.4 Market Structure 20
4 Research Methodology
4.1 Research Process 22
4.2 Primary Research 23
4.3 Secondary Research 24
4.4 Market Size Estimation 25
4.5 Forecast Model 25
5 Market Dynamics
5.1 Introduction 27
5.2 Drivers 28
5.2.1 Increasing Application in Biotech & Pharmaceutical Companies and Hospitals 28
5.2.2 Growing Number of Patients in Need of Organ Transplantation 28
5.2.3 Rise in the Patient Population Affected by Cancer 29
5.3 Restraints 29
5.3.1 High Cost of Equipment 29
5.3.2 Developing Stable and Authentic Cell Lines 29
5.4 Opportunities 30
5.4.1 Entering Untapped Markets 30
5.4.2 Increasing Use of cell Line Culture in Cancer and Stem Cell Research 30
6 Market Factor Analysis
6.1 Porters Five Forces Analysis 32
6.1.1 Bargaining Power of Suppliers 32
6.1.2 Bargaining Power of Buyers 32
6.1.3 Threat of New Entrants 32
6.1.4 Threat of Substitutes 33
6.1.5 Intensity of Rivalry 33
6.2 Supply Chain Analysis 33
6.2.1 R&D 33
6.2.2 Manufacturing 33
6.2.3 Distribution & Sales 34
6.2.4 Post-Sales Monitoring 34
6.3 Investment Opportunities 34
6.4 Pricing Analysis 34
7 Immortalized Cell Line Market, by Method
7.1 Overview 36
7.1.1 Virus Induction 38
7.1.2 HTERT Expression 39
7.1.3 Inactivation of Tumour Suppression Genes 40
7.1.4 Others 40
8 Immortalized Cell Line Market, by Application
8.1 Overview 42
8.1.1 Diagnostics 43
8.1.2 Drug Discovery 43
8.1.3 Vaccine Production 44
8.1.4 Tissue Engineering and Regenerative Medicines 45
8.1.5 Others 45
9 Immortalized Cell Line Market, by End-user
9.1 Overview 47
9.1.1 Introduction 47
9.1.2 Pharmaceutical and Biopharmaceutical Companies 48
9.1.3 Contract Research Organizations 48
9.1.4 Research Laboratories 49
10 Global Immortalized Cell Line Market, By Region
10.1 Overview 51
10.2 Americas 52
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.2.1 North America 54
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.2.1.1 US 57
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.2.1.2 Canada 58
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.2.2 South America 60
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3 Europe 62
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3.1 Western Europe 65
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3.1.1 Germany 67
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3.1.2 France 69
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3.1.3 UK 71
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3.1.4 Italy 73
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3.1.5 Spain 75
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3.1.6 Rest of Western Europe 76
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.3.2 Eastern Europe 78
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.4 Asia-Pacific 80
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.4.1 Japan 82
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.4.2 China 84
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.4.3 India 86
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.4.4 South Korea 87
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.4.5 Rest of Asia-Pacific 89
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.5 Middle East and Africa 91
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.5.1 Middle East 93
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
10.5.2 Africa 95
Immortalized Cell Line Market, by Method
Immortalized Cell Line Market, by Application
Immortalized Cell Line Market, by End-user
11 Competitive Landscape
11.1 Company Market Share Analysis 98
11.1.1 Introduction 98
11.2 Competitive Landscape 99
11.2.1 Introduction 99
11.3 Key Developments 100
12 Company Profiles
12.1 Thermo Fisher Scientific 102
12.1.1 Company Overview 102
12.1.2 Financial Overview 102
12.1.3 Products Offered 103
12.1.4 Key Developments 103
12.1.5 SWOT Analysis 103
12.1.6 Key Strategies 104
12.2 ATCC (American Type Culture Collection Inc.) 105
12.2.1 Company Overview 105
12.2.2 Financial Overview 105
12.2.3 Products Offered 105
12.2.4 Key Developments 106
12.2.5 SWOT Analysis 107
12.2.6 Key Strategies 107
12.3 Valneva 108
12.3.1 Company Overview 108
12.3.2 Financial Overview 108
12.3.3 Products Offered 108
12.3.4 1.3.4 Key Developments 109
12.3.5 SWOT Analysis 109
12.3.6 Key Strategies 109
12.4 Sartorius AG 110
12.4.1 Company Overview 110
12.4.2 Financial Overview 110
12.4.3 Products Offered 111
12.4.4 Key Developments 111
12.4.5 SWOT Analysis 111
12.4.6 Key Strategies 111
12.5 Lonza Group, AG 112
12.5.1 Company Overview 112
12.5.2 Financial Overview 112
12.5.3 Products Offered 112
12.5.4 Key Developments 113
12.5.5 Swot Analysis 113
12.5.6 Key Strategies 113
12.6 Merck KGaA 114
12.6.1 Company Overview 114
12.6.2 Financial Overview 114
12.6.3 Products Offered 115
12.6.4 Key Developments 115
12.6.5 SWOT Analysis 115
12.6.6 Key Strategies 115
12.7 Selexis SA 116
12.7.1 Company Overview 116
12.7.2 Financial Overview 116
12.7.3 Products Offered 116
12.7.4 Key Developments 116
12.7.5 SWOT Analysis 117
12.7.6 Key Strategies 117
12.8 Wuxi App Tec 118
12.8.1 Company Overview 118
12.8.2 Financial Overview 118
12.8.3 Products Offered 119
12.8.4 Key Developments 119
12.8.5 SWOT Analysis 119
12.8.6 Key Strategies 119
12.9 European Collection of Authenticated Cell Cultures (ECACC) 120
12.9.1 Company Overview 120
12.9.2 Financial Overview 120
12.9.3 Products Offered 120
12.9.4 Key Developments 120
12.9.5 SWOT Analysis 121
12.9.6 Key Strategies 121
12.10 Corning Incorporated 122
12.10.1 Company Overview 122
12.10.2 Financial Overview 122
12.10.3 Products Offered 123
12.10.4 Key Developments 123
12.10.5 SWOT Analysis 123
12.10.6 Key Strategies 123
13 Appendix
13.1 Discussion Blue Print 125
14 List of Tables
TABLE 1 MARKET SYNOPSIS 17
TABLE 2 LIST OF ASSUMPTIONS 19
TABLE 3 GLOBAL IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 36
TABLE 4 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 37
TABLE 5 GLOBAL IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 37
TABLE 6 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY REGION 2020–2027 (USD MILLION) 38
TABLE 7 GLOBAL IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY REGION 2020–2027 (USD MILLION) 39
TABLE 8 GLOBAL IMMORTALIZED CELL LINE MARKET FOR INACTIVATION OF TUMOUR SUPPRESSION GENES, BY REGION 2020–2027 (USD MILLION) 40
TABLE 9 GLOBAL IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 42
TABLE 10 GLOBAL IMMORTALIZED CELL LINE MARKET FOR DIAGNOSTICS, BY REGION 2020–2027 (USD MILLION) 43
TABLE 11 GLOBAL IMMORTALIZED CELL LINE MARKET FOR DRUG DISCOVERY, BY REGION 2020–2027 (USD MILLION) 43
TABLE 12 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VACCINE PRODUCTION, BY REGION 2020–2027 (USD MILLION) 44
TABLE 13 GLOBAL IMMORTALIZED CELL LINE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION 2020–2027 (USD MILLION) 45
TABLE 14 GLOBAL IMMORTALIZED CELL LINE MARKET, BY END-USERS 2020–2027 (USD MILLION) 47
TABLE 15 GLOBAL IMMORTALIZED CELL LINE MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION 2020–2027 (USD MILLION) 48
TABLE 16 GLOBAL IMMORTALIZED CELL LINE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION 2020–2027 (USD MILLION) 48
TABLE 17 GLOBAL IMMORTALIZED CELL LINE MARKET FOR RESEARCH LABORATORIES, BY REGION 2020–2027 (USD MILLION) 49
TABLE 18 GLOBAL IMMORTALIZED CELL LINE MARKET, BY REGION 2020–2027 (USD MILLION) 51
TABLE 19 GLOBAL IMMORTALIZED CELL LINE MARKET, BY REGION 2020 & 2027 (USD MILLION) 51
TABLE 20 AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2020–2027 (USD MILLION) 52
TABLE 21 AMERICAS IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 53
TABLE 22 AMERICAS IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 53
TABLE 23 AMERICAS IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 53
TABLE 24 AMERICAS IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 54
TABLE 25 AMERICAS IMMORTALIZED CELL LINE MARKET, BY END-USERS 2020–2027 (USD MILLION) 54
TABLE 26 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY COUNTRY 2020–2027 (USD MILLION) 54
TABLE 27 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 55
TABLE 28 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 55
TABLE 29 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 56
TABLE 30 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 56
TABLE 31 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY END-USER 2020–2027 (USD MILLION) 56
TABLE 32 US IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 57
TABLE 33 US IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 57
TABLE 34 US IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 57
TABLE 35 US IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 58
TABLE 36 US IMMORTALIZED CELL LINE MARKET, BY END-USER 2020–2027 (USD MILLION) 58
TABLE 37 CANADA IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USDMILLION) 58
TABLE 38 CANADA IMMORTALIZED CELL LINE MARKET FOR VIRCANADA INDUCTION, BY TYPE 2020–2027 (USDMILLION) 59
TABLE 39 CANADA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USDMILLION) 59
TABLE 40 CANADA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USDMILLION) 59
TABLE 41 CANADA IMMORTALIZED CELL LINE MARKET, BY END-USER 2020–2027 (USDMILLION) 60
TABLE 42 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 60
TABLE 43 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET FOR VIRSOUTH AMERICA INDUCTION, BY TYPE 2020–2027 (USD MILLION) 60
TABLE 44 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 61
TABLE 45 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 61
TABLE 46 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY END-USER 2020–2027 (USD MILLION) 61
TABLE 47 EUROPE IMMORTALIZED CELL LINE MARKET, BY REGION 2020–2027 (USD MILLION) 62
TABLE 48 EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 63
TABLE 49 EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 63
TABLE 50 EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 63
TABLE 51 EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 64
TABLE 52 EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 64
TABLE 53 WESTERN EUROPE: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 65
TABLE 54 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 65
TABLE 55 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 66
TABLE 56 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 66
TABLE 57 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 66
TABLE 58 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 67
TABLE 59 GERMANY IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 67
TABLE 60 GERMANY IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 67
TABLE 61 GERMANY IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 68
TABLE 62 GERMANY IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 68
TABLE 63 GERMANY IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 68
TABLE 64 FRANCE IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 69
TABLE 65 FRANCE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 69
TABLE 66 FRANCE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 69
TABLE 67 FRANCE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 70
TABLE 68 FRANCE IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 70
TABLE 69 U.K IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 71
TABLE 70 U.K IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 71
TABLE 71 U.K IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 71
TABLE 72 U.K IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 72
TABLE 73 U.K IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 72
TABLE 74 ITALY IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 73
TABLE 75 ITALY IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 73
TABLE 76 ITALY IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 73
TABLE 77 ITALY IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 74
TABLE 78 ITALY IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 74
TABLE 79 SPAIN IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 75
TABLE 80 SPAIN IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 75
TABLE 81 SPAIN IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 75
TABLE 82 SPAIN IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 76
TABLE 83 SPAIN IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 76
TABLE 84 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 76
TABLE 85 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 77
TABLE 86 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 77
TABLE 87 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 77
TABLE 88 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 78
TABLE 89 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 78
TABLE 90 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 78
TABLE 91 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 79
TABLE 92 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 79
TABLE 93 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 79
TABLE 94 ASIA PACIFIC: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 95 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 81
TABLE 96 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 81
TABLE 97 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 81
TABLE 98 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 82
TABLE 99 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 82
TABLE 100 JAPAN IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 82
TABLE 101 JAPAN IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 83
TABLE 102 JAPAN IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 83
TABLE 103 JAPAN IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 83
TABLE 104 JAPAN IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 84
TABLE 105 CHINA IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 84
TABLE 106 CHINA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 84
TABLE 107 CHINA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 85
TABLE 108 CHINA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 85
TABLE 109 CHINA IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 85
TABLE 110 INDIA IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 86
TABLE 111 INDIA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 86
TABLE 112 INDIA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 86
TABLE 113 INDIA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 87
TABLE 114 INDIA IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 87
TABLE 115 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 87
TABLE 116 SOUTH KOREA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 88
TABLE 117 SOUTH KOREA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 88
TABLE 118 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 88
TABLE 119 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 89
TABLE 120 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 89
TABLE 121 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 89
TABLE 122 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 90
TABLE 123 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 90
TABLE 124 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 90
TABLE 125 MIDDLE EAST AND AFRICA: IMMORTALIZED CELL LINE MARKET, BY REGION, 2020–2027 (USD MILLION) 91
TABLE 126 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 92
TABLE 127 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 92
TABLE 128 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 92
TABLE 129 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 93
TABLE 130 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 93
TABLE 131 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 93
TABLE 132 MIDDLE EAST IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 94
TABLE 133 MIDDLE EAST IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 94
TABLE 134 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 94
TABLE 135 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 95
TABLE 136 AFRICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2020–2027 (USD MILLION) 95
TABLE 137 AFRICA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2020–2027 (USD MILLION) 95
TABLE 138 AFRICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2020–2027 (USD MILLION) 96
TABLE 139 AFRICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020–2027 (USD MILLION) 96
TABLE 140 AFRICA IMMORTALIZED CELL LINE MARKET, BY END USERS 2020–2027 (USD MILLION) 96
TABLE 141 GLOBAL IMMORTALIZED CELL LINE MARKET: KEY DEVELOPMENTS 100
15 List of Figures
FIGURE 1 GLOBAL IMMORTALIZED CELL LINE MARKET: MARKET STRUCTURE 20
FIGURE 2 RESEARCH PROCESS OF MRFR 22
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 25
FIGURE 4 PORTERS FIVE FORCES ANALYSIS OF GLOBAL IMMORTALIZED CELL LINE MARKET 32
FIGURE 5 SUPPLY CHAIN: GLOBAL IMMORTALIZED CELL LINE MARKET 33
FIGURE 6 GLOBAL IMMORTALIZED CELL LINE MARKET, BY METHOD 2020 & 2027 (USD MILLION) 36
FIGURE 7 GLOBAL IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 42
FIGURE 8 GLOBAL IMMORTALIZED CELL LINE MARKET, BY END-USERS 2020 & 2027 (USD MILLION) 47
FIGURE 9 AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2020 (%) 52
FIGURE 10 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2020 (%) 55
FIGURE 11 EUROPE: IMMORTALIZED CELL LINE MARKET SHARE, BY REGION, 2020 (% SHARE) 62
FIGURE 12 WESTERN EUROPE: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2020 (%) 65
FIGURE 13 ASIA PACIFIC: IMMORTALIZED CELL LINE MARKET SHARE, BY COUNTRY, 2020 (%) 80
FIGURE 14 THE MIDDLE EAST AND AFRICA: IMMORTALIZED CELL LINE MARKET SHARE, BY REGION, 2020 (%) 91
FIGURE 15 GLOBAL IMMORTALIZED CELL LINE MARKET, MARKET SHARE ANALYSIS 2020 (%) 98
FIGURE 16 GLOBAL IMMORTALIZED CELL LINE MARKET COMPETITIVE LANDSCAPE (%) 99
